7 X 11 Long.P65
Total Page:16
File Type:pdf, Size:1020Kb
Cambridge University Press 978-0-521-85056-8 - The Spectrum of Psychotic Disorders: Neurobiology, Etiology, and Pathogenesis Edited by Daryl Fujii and Iqbal Ahmed Index More information Index abacavir 424 catatonia 234 absence seizures 264, 265 human immunodeficiency virus 318 abstract attitude 20 affective flattening, autism 238–9 acetylcholine receptor systems, dementia with aggression Lewy bodies 481 Alzheimer’s disease 458 acute and transient psychotic disorders (ATPD) delusional disorder 121 age at onset 103 alcoholism, delusional disorder association 127–8 antipsychotic medication 111 alprazolam 402 course 105–7 Alzheimer’s disease duration of treatment 111 dementia with Lewy bodies linkage 482 epidemiology 535 prodromal stage 160 gender 102–3 visual hallucinations 524, 525 genetics 108–9 Alzheimer’s disease-related psychosis 455–6 neurochemical abnormalities 108 age of onset 456–7 neuroimaging 107 associated symptoms 458 neuropathology 107 brain changes 459 outcome 106 course 458–9 presentation 103–4 epidemiology 456, 537 progression 105–7 genetic factors 461–4 psychogenic 110 linkage analysis 461–2 reactive 110 neurochemical abnormalities 460 serine 108 neuropathology 459 treatment 110–2. See also brief psychotic onset of psychosis disorder presentation 457–8 acyclovir, herpes simplex encephalitis 321, 322 progression 458–9 addiction hypothesis, primary 374–5 putative psychosis genes 462–3 adrenocortical insufficiency 356–7 symptoms 457–8 adrenoleukodystrophy, X-linked 353–7 treatment 464–6 age of onset 354 amantadine brain changes 355–6 Parkinson’s disease 493, 502 course 354–5 psychosis risk 423 environmental risk factors 356 amino acids, brief and acute psychoses 108 epidemiology 354 amitriptyline 430 genetic factors 356 amphetamines 434 neurochemical abnormalities 356 Andermann syndrome 207 neuroimaging 355–6 angel’s trumpet 431 neuropathology 355–6 angiotensin converting enzyme (ACE) inhibitors presentation 354 411 progression 354–5 angiotensin receptor blockers 411 temporal lobe pathology 535–6 anosognosia 288 treatment 356–7 antibiotics very long chain fatty acids 355–6 Lyme disease treatment 325 adrenomyeloneuropathy 355 psychosis induction 410, 426–7 affective disorders syphilis treatment 328–9 557 © Cambridge University Press www.cambridge.org Cambridge University Press 978-0-521-85056-8 - The Spectrum of Psychotic Disorders: Neurobiology, Etiology, and Pathogenesis Edited by Daryl Fujii and Iqbal Ahmed Index More information 558 Index anticholinergic medication 423–4 anxiety cholinergic rebound 432–3 brief psychotic disorder 105 Parkinson’s disease 493 epidemiology 536 psychosis induction 430–1 human immunodeficiency virus 318 anticonvulsants schizophreniform disorder 105 bipolar disorder treatment 147 apathy 540–1 cerebrovascular accident 298–9 apolipoprotein E4 (APOE4) allele corticosteroid-induced psychosis 419 Alzheimer’s disease 463–4 traumatic brain injury 255, 256 dementia with Lewy bodies 482 visual hallucinations 525 aripiprazole antidepressant-induced psychosis 407, 410 Alzheimer’s disease 464–5 neurochemistry 409 methamphetamine-induced psychosis 401 presentation 409 Parkinson’s disease-induced psychosis 504 treatment 410 arylsulphatase A 351, 353 antidepressants asparaginase, psychosis risk 309 bipolar disorder 147 Asperger disorder 238 cerebrovascular accident 299 attention, dementia with Lewy bodies 475–6 major depression 180–3 autism 233–5 psychosis induction 407–10 affective flattening 238–9 serotonin and norepinephrine combination 408 age of onset 538 anti-epileptic medication-induced psychosis atypical 238 420–2 catatonia 235, 238–42 antimalarial medication, psychosis induction catatonic variant 242 427–8 cognitive deficits 237 antimycobacterial medication 429–30 conceptualization 233–42 antipsychotics course 538–9 Alzheimer’s disease 464–5 diagnosis 236–7 bipolar disorder treatment 147 electroconvulsive therapy 241 brain tumor psychosis 310–1 epilepsy association 236–7 brief and acute psychoses 111 genetic factors 236 cerebrovascular accident 298–9 hallucinations 238–9 delusional disorder 130–1 intellectual disabilities differential diagnosis epilepsy with schizophrenia-like psychosis 278 199 human immunodeficiency virus 319 medical disorders 236 hyperprolactinemia 310–1 neurological disorders 236 intellectual disabilities with psychosis 209 prevalence 236 major depression 181–3 psychosis 234–5, 237 multiple sclerosis 343 schizophrenia association 237–9 Parkinson’s disease-induced psychosis 502 speech 239–40 schizophrenia 68 symptom overlap with catatonia 241 seizure risk 279 terminology 235 systemic lupus erythematosus 348–9 thought disorders 238–9 tardive dyskinesia 210 autosomal chromosome anomalies, psychotic traumatic brain injury 255 symptoms 208 antipsychotics, atypical avoidant personality disorder 127–8 Alzheimer’s disease 465 axonal pathology in multiple sclerosis 341 bipolar disorder treatment 147 azathioprine 347–8 cannabis psychosis 376–7 cerebrovascular accident 298 baclofen 438 corticosteroid-induced psychosis 419 bacterial infections 322–9 delusional disorder 130–1 behavioral disturbance dementia with Lewy bodies 483 cocaine-induced psychosis 384, 387 epilepsy with schizophrenia-like psychosis 278 metachromatic leukodystrophy 351 intellectual disabilities with psychosis 209–10 X-linked adrenoleukodystrophy 354 methamphetamine-induced psychosis 401 benzodiazepines multiple sclerosis 343 epilepsy with schizophrenia-like psychosis Parkinson’s disease-induced psychosis 502–4 278–9 schizoaffective disorder 87–8 methamphetamine-induced psychosis 401 schizophrenia 50–1, 68–9 psychosis induction 439 traumatic brain injury 255 traumatic brain injury 255 antisocial personality, cannabis psychosis 372, 376 benztropin 430 antiviral medication, psychosis induction 424–6 Parkinson’s disease 493 © Cambridge University Press www.cambridge.org Cambridge University Press 978-0-521-85056-8 - The Spectrum of Psychotic Disorders: Neurobiology, Etiology, and Pathogenesis Edited by Daryl Fujii and Iqbal Ahmed Index More information 559 Index beta blockers 411 cognitive impairment 252 biogenic amines contribution to psychosis development depression hypothesis 411 257–8 hallucinations 494 course 252–4, 256, 538–9 bipolar disorder 138 delusions 251 age of onset 139–40 diagnosis 250–1 brain abnormalities 142–4 disconnection syndrome of memory 297 course 141–2 dopaminergic system 254 depression treatment 147 environmental risk factors 255 epidemiology 138–9, 536 epidemiology 250–1 GABA abnormalities 144 gender differences 254 gender differences 140 genetic factors 254–5 genetic factors 145, 543 hallucinations 251, 259 major depression incidence 250 association 178 kindling 258–9 conversion 159 latency 252, 253, 256, 258–9 mania 147–8 neural network changes 259 multiple sclerosis association 146 neurochemistry 254 neurochemistry 144 neuroleptics 254–6 neuropathology 142–4 neuropathology 254 outcome 142 onset 252–3 post-partum psychosis association 146 pathophysiological processes 259 presentation 140–1 presentation 251–2 prevalence 138–9 primary cause of psychosis 256 progression 141–2 prodromal symptoms 253 psychosocial functioning 142 progression 252–4, 256, 538–9 psychotic/nonpsychotic brain differences reduplicative amnesia 297 143–4 seizure disorders 251–2 recurrence 141–2 sensitization 258–9 schizoaffective disorder differential diagnosis 81 severity of injury 250 socio-environmental risk factors 146 temporal lobe pathology 535–6 subtypes 138 treatment 255, 256 symptoms 139–41 unrelated to psychosis development 258 treatment 146–8 brain tumors 302–3 velo-cardio-facial syndrome 220–2 age of onset 304–5 white matter abnormalities 143 antipsychotics 310–1 young people 140 course 305–6 bone marrow transplantation, X-linked diagnosis 305–6 adrenoleukodsytrophy 356–7 electroconvulsive therapy 311 Borrelia burgdorferi 323 epidemiology 303–4 brain genetic factors 308–9 lesions in neurological syndromes 7–8 hallucinations 305, 307 radiation effects 308–10 immunosuppression 308–9 brain changes incidence 302 Alzheimer’s disease 459 location 303, 307 auditory hallucinations 525 neurochemical abnormalities 308 cocaine-induced psychosis 385–6 neuroimaging 306 dementia with Lewy bodies 480 neuropathology 306–8 imbalances in systems 546–8 presentation 304–5 methamphetamine-induced psychosis 396–8 prevalence 303 multiple sclerosis 339–41 prognosis 305–6 neuropathological mechanisms 548 prolactin level 306 Parkinson’s disease-related psychosis 491, 498 psychiatric patients 303–4 psychosis 7–9 psychiatric symptoms 304 severity 548 psychosocial risk factors 309 systemic lupus erythematosus 346 surgery 309 temporal lobe pathology 535–6, 541–2 symptoms 304–6 white matter 143, 222–3, 541–2 mechanisms 306 X-linked adrenoleukodystrophy 355–6 treatment 303 brain injury, traumatic 249–50 of psychosis 309–11 age of onset 251 psychosis risk 309 classification 256 types 302 © Cambridge University Press www.cambridge.org Cambridge University Press 978-0-521-85056-8 - The Spectrum of Psychotic Disorders: Neurobiology, Etiology, and Pathogenesis Edited by Daryl Fujii and Iqbal Ahmed Index More information 560 Index brief and acute psychoses schizophrenia 372, 376 antipsychotic medication 111 symptomatology 370–1 duration of treatment 111 treatment 376–7 treatment 110–2. See also acute and transient Capgras’ syndrome 288–90, 297 psychotic disorders (ATPD); brief dementia with Lewy bodies 477 psychotic disorder; schizophreniform carbamazepine disorder bipolar disorder treatment 147 brief psychotic disorder brain tumor psychosis